NeuroSense Therapeutics Ltd.

www.neurosense-tx.com

Public Company

(NASDAQ CM: NRSN)

TAGS

ALS, Biopharmaceuticals, Biotechnology, Therapeutics

General Data

Sector	Life Sciences
Sub-Sector	Biotechnology

TECHNOLOGY

A microRNA (MiRNA)-based drug.

CONTACT INFO

Personal Contact Information

Blog

Expand / Collapse All

	MANAGEMENT

Key Executive

	BOARD

Board

	FINANCIAL ROUNDS

Round

Date

Stage

Amount

Valuation

First Round - Extended

Apr. 26, 2020

R&D

$1.2m

$13.2m

General Info

Angel Company & Title
E-mail
Website
No. of Current Portfolio Companies
Remarks

Business Description

Description
Angel Activity

Investment Data

Preferences

	SECTOR SEGMENTATION (By Number Of Companies)

Current Israeli Clients (#)

	Deals Underwritten (#)

	Deals Legally Advised (#)

	Current Positions

	Previous Positions

	Background

	Education

	Specialties

Last Updated: Jan 04, 2024